Premarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication Approvals

JAMA Netw Open. 2024 May 1;7(5):e249233. doi: 10.1001/jamanetworkopen.2024.9233.

NO ABSTRACT

PMID:38691363 | DOI:10.1001/jamanetworkopen.2024.9233